Biosimilars and Biobetters September 25, 2011

Presented by the SMi Group, the 2nd annual Biosimilars and Biobetters conference will focus on aligning business & science for success. The conference will discuss how the pharma and generics industries can best approach the rapidly emerging and developing biosimilar market; how policy makers are shaping the contours of this new generic frontier; and the implications policy could have for current biologic drug development and patent protection.

Ross Lobell will speak on "The Developing Biosimilars Regulatory Framework in the USA."